Finance

Lists
Outlook: 63.6% bullish·9.1% bearish
Go to analysis
AVBP:NASDAQ
Arrivent Biopharma Inc
13,01 USD
-0,46%
(-0,060) 1D
13-ноя., 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVBP...
Open
13,00 USD
High
13,24 USD
Low
12,59 USD
Mkt. cap
672,92 млн
Avg. vol.
2,13 млн
Volume
616,14 миң
52-wk high
35,83 USD
52-wk low
11,37 USD
EPS
-3,65 USD
Shares outstanding
51,72 млн
No. of employees
77
Open
13,00 USD
High
13,24 USD
Low
12,59 USD
Mkt. cap
672,92 млн
Avg. vol.
2,13 млн
Volume
616,14 миң
52-wk high
35,83 USD
52-wk low
11,37 USD
EPS
-3,65 USD
Shares outstanding
51,72 млн
No. of employees
77
News stories
From web sources and news partners
About Arrivent Biopharma Inc
CEO-
Employees77
Founded2021
HeadquartersНьютаун сквер, Пенсильвания, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Analyst ratings
Based on 11 analysts giving stock ratings to AVBP in the past 3 months
Strong buy
Buy
11
Hold
0
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for AVBP in the last 3 months.
Highest
Current 13,01 USD
30,00 USD (+130,59%)
Average
24,20 USD (+86,01%)
Lowest
15,00 USD (+15,30%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yigal Nochomovitz
Citi
Buy
Maintained
23,00 USD
+76,8%
11/11/2026
Supawat Thongthip
Truist Financial
Buy
Maintained
24,00 USD
+84,5%
11/10/2026
Boris Peaker
JonesTrading
Buy
Maintained
22,00 USD
+69,1%
11/10/2026
Jeff Jones
Oppenheimer
Buy
Maintained
25,00 USD
+92,2%
11/10/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
27,00 USD
+107,5%
11/10/2026
Jeet Mukherjee
BTIG
Buy
Maintained
29,00 USD
+122,9%
11/09/2026
Michael Schmidt
Guggenheim
Buy
Maintained
30,00 USD
+130,6%
10/26/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
-
-
10/25/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
29,00 USD
+122,9%
10/20/2026
Kelly Shi
Jefferies
Buy
Maintained
18,00 USD
+38,4%
10/06/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
15,00 USD
+15,3%
10/06/2026
Asthika Goonewardene
Leerink Partners
Buy
Maintained
45,00 USD
+245,9%
08/13/2026
Soumit Roy
JonesTrading
Buy
Maintained
45,00 USD
+245,9%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
-
-
-
5,00 млн
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32,18 млн
37,62 млн
42,34 млн
38,90 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,65 млн
8,49 млн
10,35 млн
9,48 млн
Operating expense
38,82 млн
46,11 млн
52,69 млн
48,38 млн
Total operating expenses
38,82 млн
46,11 млн
52,69 млн
48,38 млн
Operating income
-38,82 млн
-46,11 млн
-52,69 млн
-43,38 млн
Other non operating income
-
-
-
-
EBT including unusual items
-35,96 млн
-43,32 млн
-49,89 млн
-40,51 млн
EBT excluding unusual items
-35,54 млн
-43,32 млн
-49,89 млн
-40,31 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-35,96 млн
-43,32 млн
-49,89 млн
-40,51 млн
Net profit margin
-
-
-
-810,24%
Earnings per share
-0,78
-0,96
-1,05
-0,81
Interest and investment income
3,28 млн
2,79 млн
2,80 млн
3,06 млн
Interest expense
-
-
-
-
Net interest expenses
3,28 млн
2,79 млн
2,80 млн
3,06 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору